Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb

NCT00866242 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Reactogenicity met study halting criteria

Conditions

Shigella

Interventions

BIOLOGICAL: CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]